191 related articles for article (PubMed ID: 38396211)
1. Remuneration of donors for cell and gene therapies: an update on the principles and perspective of the World Marrow Donor Association.
Hamad L; Ahmed SM; van Eerden E; van Walraven SM; ; Machin L
Bone Marrow Transplant; 2024 May; 59(5):580-586. PubMed ID: 38396211
[TBL] [Abstract][Full Text] [Related]
2. Remuneration of hematopoietic stem cell donors: principles and perspective of the World Marrow Donor Association.
Boo M; van Walraven SM; Chapman J; Lindberg B; Schmidt AH; Shaw BE; Switzer GE; Yang E; Egeland T;
Blood; 2011 Jan; 117(1):21-5. PubMed ID: 20921337
[TBL] [Abstract][Full Text] [Related]
3. Facilitating the ethical sourcing of donor hematopoietic stem cells for cell and gene therapy research and development.
Hamad L; Chekar CK; Anthias C; Machin L
Regen Med; 2024 Jun; ():1-10. PubMed ID: 38889086
[TBL] [Abstract][Full Text] [Related]
4. Donor safety: the role of the WMDA in ensuring the safety of volunteer unrelated donors: clinical and ethical considerations.
Shaw BE; Ball L; Beksac M; Bengtsson M; Confer D; Diler S; Fechter M; Greinix H; Koh M; Lee S; Nicoloso-De-Faveri G; Philippe J; Pollichieni S; Pulsipher M; Schmidt A; Yang E; van Walraven AM; ;
Bone Marrow Transplant; 2010 May; 45(5):832-8. PubMed ID: 20173787
[TBL] [Abstract][Full Text] [Related]
5. Emerging technologies for quality control of cell-based, advanced therapy medicinal products.
Zia S; Pizzuti V; Paris F; Alviano F; Bonsi L; Zattoni A; Reschiglian P; Roda B; Marassi V
J Pharm Biomed Anal; 2024 Aug; 246():116182. PubMed ID: 38772202
[TBL] [Abstract][Full Text] [Related]
6. Goals and activities of the WMDA. World Marrow Donor Association.
Gahrton G
Int J Hematol; 2002 Aug; 76 Suppl 1():384-5. PubMed ID: 12430887
[TBL] [Abstract][Full Text] [Related]
7. Advanced therapy medicinal products and health technology assessment principles and practices for value-based and sustainable healthcare.
Jönsson B; Hampson G; Michaels J; Towse A; von der Schulenburg JG; Wong O
Eur J Health Econ; 2019 Apr; 20(3):427-438. PubMed ID: 30229376
[TBL] [Abstract][Full Text] [Related]
8. The World Marrow Donor Association: 20 years of international collaboration for the support of unrelated donor and cord blood hematopoietic cell transplantation.
Petersdorf EW
Bone Marrow Transplant; 2010 May; 45(5):807-10. PubMed ID: 20190834
[TBL] [Abstract][Full Text] [Related]
9. Marketing Regulatory Oversight of Advanced Therapy Medicinal Products (ATMPs) in Europe: The EMA/CAT Perspective.
Salmikangas P; Schuessler-Lenz M; Ruiz S; Celis P; Reischl I; Menezes-Ferreira M; Flory E; Renner M; Ferry N
Adv Exp Med Biol; 2015; 871():103-30. PubMed ID: 26374215
[TBL] [Abstract][Full Text] [Related]
10. The Relevance of Advanced Therapy Medicinal Products in the Field of Transplantation and the Need for Academic Research Access: Overcoming Bottlenecks and Claiming a New Time.
Piemonti L; Scholz H; de Jongh D; Kerr-Conte J; van Apeldoorn A; Shaw JAM; Engelse MA; Bunnik E; Mühlemann M; Pal-Kutas K; Scott WE; Magalon J; Kugelmeier P; Berishvili E
Transpl Int; 2023; 36():11633. PubMed ID: 37822447
[TBL] [Abstract][Full Text] [Related]
11. Audit of donor centre: guidelines by the World Marrow Donor Association Quality and Regulation Working Group.
Weber M; Sacchi N; Haun S; Tistl I; Thompson S; Sengomona H; Ahmed SM; Kürsteiner O; Schwarz C; Wuchter J
Bone Marrow Transplant; 2022 Mar; 57(3):466-472. PubMed ID: 35031710
[TBL] [Abstract][Full Text] [Related]
12. Unrelated adult stem cell donor medical suitability: recommendations from the World Marrow Donor Association Clinical Working Group Committee.
Lown RN; Philippe J; Navarro W; van Walraven SM; Philips-Johnson L; Fechter M; Pawson R; Bengtsson M; Beksac M; Field S; Yang H; Shaw BE;
Bone Marrow Transplant; 2014 Jul; 49(7):880-6. PubMed ID: 24710563
[TBL] [Abstract][Full Text] [Related]
13. Standards, regulations and accreditation for registries involved in the worldwide exchange of hematopoietic stem cell donors and products.
Hurley CK; Foeken L; Horowitz M; Lindberg B; McGregor M; Sacchi N;
Bone Marrow Transplant; 2010 May; 45(5):819-24. PubMed ID: 20173794
[TBL] [Abstract][Full Text] [Related]
14. The Current State of Advanced Therapy Medicinal Products in the Czech Republic.
Kočí Z; Boráň T; Krůpa P; Kubinová Š
Hum Gene Ther Clin Dev; 2018 Sep; 29(3):132-147. PubMed ID: 29869533
[TBL] [Abstract][Full Text] [Related]
15. The World Marrow Donor Association (WMDA): its goals and activities.
Gahrton G; van Rood JJ; Oudshoorn M;
Bone Marrow Transplant; 2003 Jul; 32(2):121-4. PubMed ID: 12838274
[TBL] [Abstract][Full Text] [Related]
16. Family donor care management: principles and recommendations.
van Walraven SM; Nicoloso-de Faveri G; Axdorph-Nygell UA; Douglas KW; Jones DA; Lee SJ; Pulsipher M; Ritchie L; Halter J; Shaw BE;
Bone Marrow Transplant; 2010 Aug; 45(8):1269-73. PubMed ID: 20023708
[TBL] [Abstract][Full Text] [Related]
17. New global reporting system for serious (product) events and adverse reactions in hematopoietic stem cell donation and transplantation.
Jöris M; Pustjens E; Mengling T; Fechter M; Wiersum-Osselton J; Bokhorst A; Foeken L
Cell Tissue Bank; 2021 Jun; 22(2):191-197. PubMed ID: 32902671
[TBL] [Abstract][Full Text] [Related]
18. Administrative and research policies required to bring cellular therapies from the research laboratory to the patient's bedside.
Yim R
Transfusion; 2005 Oct; 45(4 Suppl):144S-58S. PubMed ID: 16181400
[TBL] [Abstract][Full Text] [Related]
19. Patient access to and ethical considerations of the application of the European Union hospital exemption rule for advanced therapy medicinal products.
Cuende N; Ciccocioppo R; Forte M; Galipeau J; Ikonomou L; Levine BL; Srivastava A; Zettler PJ
Cytotherapy; 2022 Jul; 24(7):686-690. PubMed ID: 35545453
[TBL] [Abstract][Full Text] [Related]
20. Cell and gene therapy investment: evolution and future outlook on investor perspectives.
Kunze-Küllmer M; Goonewardene A; Kili S; Theoharis S; Rivers P
Cytotherapy; 2024 Jul; 26(7):672-680. PubMed ID: 38483363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
